Sihuan Pharmaceutical Holdings Group Ltd.
SHPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1,146 | $951 | $950 | $805 |
| % Growth | 20.5% | 0.2% | 18% | – |
| Cost of Goods Sold | $389 | $318 | $341 | $257 |
| Gross Profit | $757 | $633 | $609 | $548 |
| % Margin | 66.1% | 66.6% | 64.1% | 68.1% |
| R&D Expenses | $153 | $308 | $196 | $298 |
| G&A Expenses | $212 | $505 | $240 | $257 |
| SG&A Expenses | $443 | $722 | $454 | $487 |
| Sales & Mktg Exp. | $231 | $217 | $213 | $230 |
| Other Operating Expenses | -$103 | -$150 | -$150 | -$252 |
| Operating Expenses | $493 | $880 | $499 | $532 |
| Operating Income | $264 | -$247 | $109 | $16 |
| % Margin | 23.1% | -26% | 11.5% | 1.9% |
| Other Income/Exp. Net | -$107 | -$162 | -$128 | -$144 |
| Pre-Tax Income | $157 | -$409 | -$19 | -$128 |
| Tax Expense | $91 | $5 | $49 | $11 |
| Net Income | $103 | -$183 | -$33 | -$4 |
| % Margin | 9% | -19.3% | -3.5% | -0.5% |
| EPS | 0.011 | -0.02 | -0.004 | -0.001 |
| % Growth | 156.6% | -450% | -620% | – |
| EPS Diluted | 0.011 | -0.02 | -0.004 | -0.001 |
| Weighted Avg Shares Out | 9,244 | 9,252 | 9,282 | 8,906 |
| Weighted Avg Shares Out Dil | 9,204 | 9,252 | 9,280 | 9,281 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $65 |
| Interest Expense | $55 | $41 | $0 | $0 |
| Depreciation & Amortization | $98 | $91 | $109 | $72 |
| EBITDA | $304 | -$280 | $114 | -$129 |
| % Margin | 26.5% | -29.4% | 12% | -16% |